John is a cardiologist with more than 15 years of combined medical practice and biopharmaceutical management experience. Before joining PhaseBio, John served as Vice President & Global Head of the Cardiovascular Center of Excellence at Quintiles Transnational Corp., where he led drug development and product lifecycle management, and established key partnerships to accelerate clinical development and research. Prior to Quintiles, John held several positions at Bristol-Myers Squibb, including Executive Director, Head of Cardiovascular/Metabolic (CV/MET) Therapeutic Area. He also served as Medical Director at Merck & Co. Earlier in his career, John was an attending cardiologist in the University of Pennsylvania’s division of cardiovascular medicine. John received a BA in biological sciences from Harvard University and an MD and PhD in biochemistry from Boston University School of Medicine.